Becton Dickinson and Co banner

Economic Moat

Becton Dickinson and has a narrow economic moat

Replacing BD’s medication systems means changing hospital software connections, retraining staff and checking that care can continue safely, making a cheaper rival less attractive. Patents on selected medical-device designs also prevent competitors from copying protected features directly, although these protections do not cover every product BD sells.

What protects Becton Dickinson and from competitors

High Switching Costs

BD’s Pyxis medication cabinets and Alaris infusion pumps connect with hospital records and staff routines. Moving to a rival requires equipment replacement, software integration, training and safety checks, creating costs beyond the purchase price; this is an inference from how these systems are installed and used.

Intangible Assets

BD holds patents covering selected drug-delivery, medication-management and other medical devices, preventing rivals from legally copying protected designs. This protection applies to particular features rather than keeping competing products out of the market altogether.

What could weaken Becton Dickinson and's moat

2 risks to watch

One for each source of the moat: what could happen and how it would weaken it